StonvexLoading…
StonvexStonvexStonvexCore line items from VABK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $77.25M | $75.93M | $69.99M | $56.73M |
Operating Income | $24.08M | $20.90M | $23.27M | $28.55M |
Net Income | $19.26M | $16.97M | $19.26M | $23.44M |
EPS (Diluted) | $3.55 | $3.15 | $3.58 | $4.38 |
Total Assets | $1.65B | $1.62B | $1.65B | $1.62B |
Total Liabilities | $1.47B | $1.46B | $1.49B | $1.49B |
Cash & Equivalents | Not available | Not available | Not available | Not available |
Free Cash Flow OCF − CapEx | $20.75M | $14.56M | $12.73M | $22.14M |
Shares Outstanding | 5.39M | 5.37M | 5.37M | 5.34M |